Coronavirus Immunoassay Core
Coronavirus Immunoassay Core
批准号:
10222402
负责人:
JAMES E Robinson
金额:
$45.62万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-30 至 2022-08-31
关键词:
2019-nCoVAcetoneAntibodiesAntibody ResponseAntiviral AgentsAreaBindingBiological AssayCancer PatientCellsCollaborationsCoronavirusDetectionEnzyme-Linked Immunosorbent AssayEquipmentFeasibility StudiesGoalsHealth SciencesImmune responseImmunityImmunoassayImmunoglobulin GImmunologic MemoryImmunologyInfectionInstitutionLaboratoriesMethanolMonoclonal AntibodiesPerformancePlasmaPopulationPopulation GroupProteinsReagentRecombinantsReproducibility of ResultsResearch PersonnelResourcesSerologic testsSerologicalSeroprevalencesSerumServicesSlideStandardizationStudy SubjectT cell responseUniversitiesViral ProteinsVirusWashingtoncoronavirus diseaseexperimental studyfollow-uphuman coronavirushuman monoclonal antibodieshuman subjectinnovationneutralizing antibodyscreeningseropositivetoolviral resistance
中文摘要
免疫学核心摘要
免疫分析核心的总体目标是提供高质量的材料,使
项目1和2中提出的研究,特别是确保研究使用试剂和预先测试
将产生可靠和可重现的结果的材料。核心将提供纯化的重组病毒
用于这两个项目的蛋白质,并提供结合和功能免疫分析方法,用于深入分析
不同人群在一段时间内对SARS CoV-2的抗体反应。堆芯做好了
由两个实验室组成,一个在杜兰,一个在华盛顿大学,它们将密切合作,实现我们的目标
英文摘要
Immunology Core Summary
The overall objective of the Immunoassay core is to provide high quality materials that will make feasible the
studies proposed in projects 1 and 2, and especially to assure that studies are using reagents and pretested
materials that will produce reliable and reproducible results. The core will provide purified recombinant viral
proteins for use in both projects and provide binding and functional immunoassays for in depth analysis of
antibody responses to SARS CoV-2 in different population groups over a period of follow-up. The core is made
up of two labs, one at Tulane and one at WSU, which will function in close collaboration to achieve our aims
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Admin-Core-001
-
批准号:10709113
-
项目类别:
-
资助金额:$43.99万
-
财政年份:2022
-
负责人:JAMES E Robinson
-
依托单位:
Longitudinal Analyses of Antibody Responses to SARS-CoV-2
-
批准号:10222403
-
项目类别:
-
资助金额:$86.02万
-
财政年份:2020
-
负责人:JAMES E Robinson
-
依托单位:
Tulane University COVID Antibody and Immunity Network (TUCAIN)
-
批准号:10222399
-
项目类别:
-
资助金额:$374.32万
-
财政年份:2020
-
负责人:JAMES E Robinson
-
依托单位:
Tulane University COVID Antibody and Immunity Network (TUCAIN)
-
批准号:10706732
-
项目类别:
-
资助金额:$43.99万
-
财政年份:2020
-
负责人:JAMES E Robinson
-
依托单位:
Tulane University COVID Antibody and Immunity Network (TUCAIN)
-
批准号:10688376
-
项目类别:
-
资助金额:$192.04万
-
财政年份:2020
-
负责人:JAMES E Robinson
-
依托单位:
Longitudinal Analyses of Antibody Responses to SARS-CoV-2
-
批准号:10688391
-
项目类别:
-
资助金额:$51.01万
-
财政年份:2020
-
负责人:JAMES E Robinson
-
依托单位:
Tulane University COVID Antibody and Immunity Network (TUCAIN)
-
批准号:10855027
-
项目类别:
-
资助金额:$279.23万
-
财政年份:2020
-
负责人:JAMES E Robinson
-
依托单位:
Coronavirus Immunoassay Core
-
批准号:10688390
-
项目类别:
-
资助金额:$37.3万
-
财政年份:2020
-
负责人:JAMES E Robinson
-
依托单位:
Human and monkey Mabs to Quaternary Epitopes
-
批准号:7904634
-
项目类别:
-
资助金额:$42.59万
-
财政年份:2010
-
负责人:JAMES E Robinson
-
依托单位:
HIV-1 gp120-Conjugate Vaccines
-
批准号:6799602
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2003
-
负责人:JAMES E Robinson
-
依托单位:
HIV-1 gp120-Conjugate Vaccines
-
批准号:6655474
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2003
-
负责人:JAMES E Robinson
-
依托单位:
RHESUS MABS FROM SHIV INFECTED MACAQUES
-
批准号:6020278
-
项目类别:
-
资助金额:$22.27万
-
财政年份:1999
-
负责人:JAMES E Robinson
-
依托单位:
RHESUS MABS FROM SHIV INFECTED MACAQUES
-
批准号:6632049
-
项目类别:
-
资助金额:$24.11万
-
财政年份:1999
-
负责人:JAMES E Robinson
-
依托单位:
RHESUS MABS FROM SHIV INFECTED MACAQUES
-
批准号:6170917
-
项目类别:
-
资助金额:$22.06万
-
财政年份:1999
-
负责人:JAMES E Robinson
-
依托单位:
RHESUS MABS FROM SHIV INFECTED MACAQUES
-
批准号:6374302
-
项目类别:
-
资助金额:$22.72万
-
财政年份:1999
-
负责人:JAMES E Robinson
-
依托单位:
RHESUS MABS FROM SHIV INFECTED MACAQUES
-
批准号:6510920
-
项目类别:
-
资助金额:$23.4万
-
财政年份:1999
-
负责人:JAMES E Robinson
-
依托单位:
ACTG--COMPARATIVE TRIALS OF ZDV VS D4T IN CHILDREN WITH HIV INFECTION
-
批准号:6253660
-
项目类别:
-
资助金额:$1.98万
-
财政年份:1997
-
负责人:JAMES E Robinson
-
依托单位:
SAFETY AND TOLERANCE OF CHRONIC NEVIRAPINE DOSING IN HIV 1 INFECTED CHILDREN
-
批准号:6253659
-
项目类别:
-
资助金额:$1.98万
-
财政年份:1997
-
负责人:JAMES E Robinson
-
依托单位:
ACTG--PHARMACOKINETICS/SAFETY AND TOLERANCE OF NEVIRAPINE
-
批准号:6253657
-
项目类别:
-
资助金额:$1.98万
-
财政年份:1997
-
负责人:JAMES E Robinson
-
依托单位:
ACTG--COMBINED ZIDOVUDINE-LAMIVUDINE (3TC) VS DDI MONOTHERAPY
-
批准号:6253680
-
项目类别:
-
资助金额:$1.98万
-
财政年份:1997
-
负责人:JAMES E Robinson
-
依托单位:
海外基金